Niva Bupa well placed to ride growth in health insurance
Get link
Facebook
X
Pinterest
Email
Other Apps
[hfe_template id='11223']
[ad_1]
Niva Bupa Health Insurance, a standalone health insurance company, plans to raise Rs 800 crore through fresh equity to augment the capital base and Rs 1,400 crore through an offer for sale by the promoter group. The stake of Bupa Singapore Holdings will fall to 56% from 62.2% after the IPO while private equity firm True North will reduce its stake to 17.5% from 26.8%.
According to IRDAI data, the share of health insurance in the gross direct premium income (GDPI) of general insurers has expanded gradually to 37.1% in FY24 from 24.6% in FY18. The health insurance GDPI grew by 19.5% annually during the period to ₹1.1 lakh crore from ₹37,000 crore. It is likely to double by FY29 according to industry estimates. This underscores the rising importance of and future scope for the health insurance segment.
ET Bureau
Given its pan-India presence, Niva Bupa is well-placed to take advantage of the opportunity. On the other hand, investors may recall the lacklustre performance of the country's largest standalone health insurer Star Health and Allied Insurance Company since its public listing in December 2021. At Wednesday's closing price of ₹481.7, it was traded way below the IPO price of ₹900 per share. Given these factors, long-term investors with a high risk appetite may consider the IPO of Niva Bupa.Business: Niva Bupa focuses on the retail health market, which forms over two-thirds of the gross written premium (GWP). The direct sales channel consisting of in-house sales teams, and online and mobile app-based sales, accounted for 13.1% of FY24 GWP, the highest among standalone health insurers. Banks and other corporates accounted for 27% of the premium income while individual agents formed 32% and brokers 27%.Financials: GWP doubled to ₹5,607.6 crore between FY22 and FY24. The combined ratio, which captures the profitability of insurance activity, improved to 98.8% from 107.5% during the period - a lower ratio is desirable. The solvency ratio improved to 2.6% from 1.7% between FY22 and FY24. The return on net worth was 5.7% in FY24.
Valuation: In December 2023, Motilal Oswal Investment Advisors through its India Business Excellence Fund IV acquired a 2.8% stake and SBI Life Insurance Company purchased a 1.3% stake at ₹67.2 per share. The weighted average acquisition cost in the past 12 months was ₹70.5. Niva demands a price-book multiple of up to 4.7 compared with 4.2 for Star Health.
Raises Rs 990 cr from Anchors
Niva Bupa Health Insurance on Wednesday raised Rs 990 crore from 32 anchor investors ahead of its IPO by allotting 133.7 million shares at the upper price band of Rs 74 apiece. Zulia Investments, Amansa Holdings, A91 Emerging Fund, Morgan Stanley Investment Funds Asia Opportunity Fund, Nippon Life India AMC, Axis Mutual Fund and Tata Balanced Advantage Fund were among the investors who participated in the round.
[hfe_template id='11223']
[ad_1]
Volatility in Indian equity markets has surged sharply over the past month, with the India VIX nearly doubling as geopolitical tensions and global uncertainty triggered aggressive selling in equities. India VIX, often referred to as the market’s fear gauge, has jumped close to 100% over the past month, reflecting growing nervousness among investors. The spike has coincided with a sharp correction in the broader market, with the Nifty 50 declining about 8% during the same period. The escalation of tensions involving the United States, Israel and Iran has intensified market anxiety in recent days, pushing crude oil prices sharply higher and triggering a global risk-off sentiment. However, analysts note that volatility had already been building even before the conflict escalated, reflecting broader concerns around global growth, foreign capital outflows and stretched valuations in equities. The heightened uncertainty translated into a sharp ...
[hfe_template id='11223']
[ad_1]
Benchmark indices Sensex and Nifty ended the week on a bearish note, closing over a percent lower each as a deepening selloff in IT stocks rattled investor sentiment amid mounting fears of AI-led disruption. Further, stronger-than-expected jobs data for January dampened hopes of a US Fed interest rate cut. Here are 7 factors that could decide market action in the coming week: 1.) Infosys, Wipro ADRs rebound - After a brutal two-day selloff that saw Infosys and Wipro ADRs plunge as much as 14.5%, Friday’s session brought a much-needed breather. Bargain hunting kicked in at lower levels, sparking a sharp rebound as Infosys climbed 3% while Wipro gained 4%—helping both stocks close the week on a far stronger note. International brokerage firm JP Morgan has a message for panic-stricken investors: IT services firms are the indispensable "plumbers of the tech world" and their dividend yields have now hit levels last seen only during ...
[hfe_template id='11223']
[ad_1]
Waaree Energies shares will be in focus on Wednesday after the solar panel maker reported a strong Q4 performance, with net profit rising 34.1% year-on-year (YoY) to Rs 618.9 crore for the quarter ended March 31, 2025. In the same quarter last year, the company had reported a profit of Rs 461.5 crore. Revenue from operations jumped 36.4% to Rs 4,003.9 crore, up from Rs 2,935.8 crore in the year-ago period, according to the company’s regulatory filing. EBITDA more than doubled to Rs 922.6 crore in Q4 FY25, up 120.6% from Rs 418.3 crore in the same quarter last year. The EBITDA margin improved to 23% from 14.3% a year ago. The company produced 2.06 GW of solar modules in the fourth quarter, up from 1.35 GW in the same period last year. For the full year, module production reached 7.13 GW, compared to 4.77 GW in FY24. For the full financial year FY25, revenue rose 27.62% YoY to Rs 14,846.06 crore. Profit after tax more than doubled to Rs 1,9...
[hfe_template id='11223']
[ad_1]
ET Bureau
Comments
Post a Comment